DJO Incorporated To Reschedule Date For Release Of Fourth Quarter And Full Year 2006 Results And Related Conference Call

Date

SAN DIEGO, CA, February 8, 2007 - DJO Incorporated, (NYSE: DJO), a global provider of products and services that promote musculoskeletal and vascular health, today announced that it will reschedule the release of its fourth quarter and full year 2006 financial results, originally scheduled for today, and the conference call to discuss those results.

The Company cited its policy to release year end financial results only upon the completion of the independent audit of its financial results. The Company said that while its year-end audit is substantially complete, certain open items remain with respect to the audit of inventory balances transferred, and in transit, from Aircast locations to DJO locations in connection with the Company's integration of the acquired Aircast operations.

The Company expects the remaining audit procedures to be completed within the next several days and the earnings release will be rescheduled shortly thereafter. The Company also said that it does not expect any delay in the filing of its Annual Report on Form 10-K with the Securities and Exchange Commission.
About DJO Incorporated

DJO Incorporated is a global provider of solutions for musculoskeletal and vascular health, specializing in rehabilitation and regeneration products for the non-operative orthopedic, spine and vascular markets. Marketed under the Aircast®, DonJoy® and ProCare® brands, the Company's broad range of over 700 rehabilitation products, including rigid knee braces, soft goods and pain management products, are used in the prevention of injury, in the treatment of chronic conditions and for recovery after surgery or injury. The Company's regeneration products consist of bone growth stimulation devices that are used to treat nonunion fractures and as an adjunct therapy after spinal fusion surgery. The Company's vascular systems products help prevent deep vein thrombosis and pulmonary embolism that can occur after orthopedic and other surgeries. Together, these products provide solutions throughout the patient's continuum of care. The Company sells its products in the United States and in more than 60 other countries through networks of agents, distributors and its own direct sales force. Customers include orthopedic, podiatric and spine surgeons, orthotic andprosthetic centers, third-party distributors, hospitals, surgery centers, physical therapists, athletic trainers, other healthcare professionals and individual and team athletes. For additional information on the Company, please visit www.djortho.com.

Company Investor/Media Contact:
DJO Incorporated
Mark Francois
Director of Corporate Communications & Investor Relations
760-734-4766

Mark.Francois@djoglobal.com

 

File